These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10391880)

  • 21. On the interaction between a bactericidal antibody and a PorA epitope of Neisseria meningitidis in outer membrane vesicles: a competitive fluorescence polarization immunoassay.
    van den Elsen JM; van Pomeren E; Poolman JT; Wilting J; Herron JN; Crommelin DJ
    Anal Biochem; 1997 May; 247(2):382-8. PubMed ID: 9177702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of class 5 antigens by meningococcal strains obtained from patients in Brazil and evaluation of two new monoclonal antibodies.
    De Gaspari E; Zollinger W
    Braz J Infect Dis; 2001 Jun; 5(3):143-53. PubMed ID: 11506778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of meningococcal epitopes in LamB of Escherichia coli and the stimulation of serosubtype-specific antibody responses.
    McCarvil J; McKenna AJ; Grief C; Hoy CS; Sesardic D; Maiden MC; Feavers IM
    Mol Microbiol; 1993 Oct; 10(1):203-13. PubMed ID: 7526119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies.
    Poolman JT; Kriz-Kuzemenska P; Ashton F; Bibb W; Dankert J; Demina A; Frøholm LO; Hassan-King M; Jones DM; Lind I
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):69-72. PubMed ID: 7719916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine.
    van der Voort ER; van Dijken H; Kuipers B; van der Biezen J; van der Ley P; Meylis J; Claassen I; Poolman J
    Infect Immun; 1997 Dec; 65(12):5184-90. PubMed ID: 9393814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to meningococcal class 1 outer membrane proteins in South African complement-deficient and complement-sufficient subjects.
    Orren A; Warren RE; Potter PC; Jones AM; Lachmann PJ; Poolman JT
    Infect Immun; 1992 Nov; 60(11):4510-6. PubMed ID: 1398965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG antibody levels to meningococcal porins in patient sera: comparison of immunoblotting and ELISA measurements.
    Wedege E; Bolstad K; Wetzler LM; Guttormsen H
    J Immunol Methods; 2000 Oct; 244(1-2):9-15. PubMed ID: 11033014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine.
    Martin SL; Borrow R; van der Ley P; Dawson M; Fox AJ; Cartwright KA
    Vaccine; 2000 May; 18(23):2476-81. PubMed ID: 10775781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.
    McGuinness B; Barlow AK; Clarke IN; Farley JE; Anilionis A; Poolman JT; Heckels JE
    J Exp Med; 1990 Jun; 171(6):1871-82. PubMed ID: 1693651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine.
    Vermont CL; van Dijken HH; Kuipers AJ; van Limpt CJ; Keijzers WC; van der Ende A; de Groot R; van Alphen L; van den Dobbelsteen GP
    Infect Immun; 2003 Apr; 71(4):1650-5. PubMed ID: 12654777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis.
    Michaelsen TE; Kolberg J; Aase A; Herstad TK; Høiby EA
    Scand J Immunol; 2004 Jan; 59(1):34-9. PubMed ID: 14723619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine.
    Milagres LG; Gorla MC; Sacchi CT; Rodrigues MM
    Infect Immun; 1998 Oct; 66(10):4755-61. PubMed ID: 9746575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of in vitro folded outer membrane protein PorA of Neisseria meningitidis.
    Jansen C; Kuipers B; van der Biezen J; de Cock H; van der Ley P; Tommassen J
    FEMS Immunol Med Microbiol; 2000 Mar; 27(3):227-33. PubMed ID: 10683467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine.
    Wedege E; Kuipers B; Bolstad K; van Dijken H; Frøholm LO; Vermont C; Caugant DA; van den Dobbelsteen G
    Infect Immun; 2003 Jul; 71(7):3775-81. PubMed ID: 12819059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterologous production of the P1 porin of Neisseria meningitidis in bacillus subtilis: the effect of an N-terminal extension on the presentation of native-like epitopes.
    Muttilainen S; Butcher SJ; Runeberg K; Nurminen M; Idänpään-Heikkilä I; Wahlström E; Sarvas M
    Microb Pathog; 1995 May; 18(5):365-71. PubMed ID: 7476101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.
    Sacchi CT; Lemos AP; Popovic T; De Morais JC; Whitney AM; Melles CE; Brondi LM; Monteiro LM; Paiva MV; Solari CA; Mayer LW
    J Clin Microbiol; 2001 Aug; 39(8):2897-903. PubMed ID: 11474010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design.
    Feavers IM; Fox AJ; Gray S; Jones DM; Maiden MC
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):444-50. PubMed ID: 8807211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase variation of PorA, a major outer membrane protein, mediates escape of bactericidal antibodies by Neisseria meningitidis.
    Tauseef I; Ali YM; Bayliss CD
    Infect Immun; 2013 Apr; 81(4):1374-80. PubMed ID: 23403557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neisseria meningitidis PorA variable regions: rapid detection of P1.7 and P1.19 variants by PCR.
    de Filippis I; de Andrade CF; de Almeida AE; Clementino MM; Fernandes CA; de Carvalho ML; Vicente AC
    Lett Appl Microbiol; 2007 Oct; 45(4):426-31. PubMed ID: 17897387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes.
    Arigita C; Kersten GF; Hazendonk T; Hennink WE; Crommelin DJ; Jiskoot W
    Vaccine; 2003 Feb; 21(9-10):950-60. PubMed ID: 12547608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.